|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:awards
|
Best Startup 2020
|
|
gptkbp:ceo
|
gptkb:Jane_Doe
|
|
gptkbp:certification
|
gptkb:standard
|
|
gptkbp:clinical_trial
|
ongoing
|
|
gptkbp:collaborations
|
gptkb:University_of_California
|
|
gptkbp:committee
|
experts in genetics
|
|
gptkbp:community_engagement
|
health awareness programs
|
|
gptkbp:community_involvement
|
school programs
|
|
gptkbp:competitors
|
gptkb:Bio_Gen_Corp
|
|
gptkbp:conference
|
Annual Biotech Summit
|
|
gptkbp:customer_base
|
hospitals and clinics
|
|
gptkbp:employees
|
gptkb:television_series
|
|
gptkbp:expansion_plans
|
international markets
|
|
gptkbp:founded
|
gptkb:2001
|
|
gptkbp:founder
|
gptkb:John_E._Smith
|
|
gptkbp:grants
|
3 million USD
|
|
gptkbp:headcount
|
250
|
|
gptkbp:headquarters
|
gptkb:San_Francisco
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Gen Tech Labs
|
|
gptkbp:industry
|
gptkb:Company
|
|
gptkbp:invention
|
gptkb:10
|
|
gptkbp:investment
|
Venture Capital Firm A
5 million USD in 2021
|
|
gptkbp:market
|
gptkb:North_America
|
|
gptkbp:mission
|
advancing genetic research
|
|
gptkbp:partnership
|
Tech Company B
|
|
gptkbp:partnerships
|
various research institutions
|
|
gptkbp:products
|
genetic testing
|
|
gptkbp:publishes
|
50 peer-reviewed articles
|
|
gptkbp:research_focus
|
personalized medicine
|
|
gptkbp:revenue
|
50 million USD
20%
|
|
gptkbp:services
|
DNA sequencing
|
|
gptkbp:social_media
|
@ Gen Tech Labs
|
|
gptkbp:subsidiary
|
Gen Tech Diagnostics
|
|
gptkbp:sustainability_initiatives
|
green lab practices
|
|
gptkbp:technology
|
gptkb:CRISPR
|
|
gptkbp:website
|
www.gentechlabs.com
|
|
gptkbp:bfsParent
|
gptkb:Weyland_Pharmaceuticals_Division
|
|
gptkbp:bfsLayer
|
6
|